DE602005009158D1 - Anti-hiv-chinuklidinverbindungen - Google Patents

Anti-hiv-chinuklidinverbindungen

Info

Publication number
DE602005009158D1
DE602005009158D1 DE602005009158T DE602005009158T DE602005009158D1 DE 602005009158 D1 DE602005009158 D1 DE 602005009158D1 DE 602005009158 T DE602005009158 T DE 602005009158T DE 602005009158 T DE602005009158 T DE 602005009158T DE 602005009158 D1 DE602005009158 D1 DE 602005009158D1
Authority
DE
Germany
Prior art keywords
infectivity
mammal
chinuklidinverbindungen
hiv
benzoylquinuclidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005009158T
Other languages
English (en)
Inventor
Laurent Lecanu
Janet Greeson
Vassilios Papadopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Samaritan Pharmaceuticals Inc
Original Assignee
Georgetown University
Samaritan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University, Samaritan Pharmaceuticals Inc filed Critical Georgetown University
Publication of DE602005009158D1 publication Critical patent/DE602005009158D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DE602005009158T 2004-04-05 2005-04-01 Anti-hiv-chinuklidinverbindungen Expired - Fee Related DE602005009158D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55955004P 2004-04-05 2004-04-05
US59020904P 2004-07-22 2004-07-22
PCT/US2005/011372 WO2006085890A2 (en) 2004-04-05 2005-04-01 Anti-hiv quinuclidine compounds

Publications (1)

Publication Number Publication Date
DE602005009158D1 true DE602005009158D1 (de) 2008-10-02

Family

ID=36793472

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005009158T Expired - Fee Related DE602005009158D1 (de) 2004-04-05 2005-04-01 Anti-hiv-chinuklidinverbindungen

Country Status (8)

Country Link
US (1) US20080194619A1 (de)
EP (1) EP1732547B1 (de)
JP (1) JP2007531792A (de)
AT (1) ATE405263T1 (de)
AU (1) AU2005327283A1 (de)
CA (1) CA2563109A1 (de)
DE (1) DE602005009158D1 (de)
WO (1) WO2006085890A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012312301A1 (en) * 2011-09-22 2014-03-20 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of choline kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2527211A1 (en) * 2003-06-02 2004-12-16 Samaritan Pharmaceuticals, Inc. Anti-hiv benzamide compounds
TWI363759B (en) * 2004-04-27 2012-05-11 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists

Also Published As

Publication number Publication date
CA2563109A1 (en) 2006-08-17
EP1732547A2 (de) 2006-12-20
AU2005327283A1 (en) 2006-08-17
ATE405263T1 (de) 2008-09-15
JP2007531792A (ja) 2007-11-08
US20080194619A1 (en) 2008-08-14
EP1732547B1 (de) 2008-08-20
WO2006085890A3 (en) 2006-12-07
WO2006085890A2 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
EA201591610A1 (ru) Ингибиторы кинуренинового пути
EA201000914A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
EA201490163A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
AR072442A1 (es) Metodo para la terapia del cancer, uso, kit
EA201391108A1 (ru) Лечение липодистрофии
AR109103A1 (es) Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert
NO20063716L (no) Anvendelse av lavdose erytropoietin ved stimulering av endotel forloperceller, regenerering av organer og sinking av progresjonen av sluttorganskader
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
EA201790406A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
AR082803A1 (es) Metodos y formulaciones para el tratamiento de la trombosis con betrixaban y un inhibidor de la glicoproteina p
CY1115245T1 (el) Φαρμακευτικη συνθεση που συνδυαζει διαφορους φλεβοτονικους και αγγειοπροστατευτικους παραγοντες για τη θεραπεια χρονιας φλεβικης ανεπαρκειας
WO2020033838A3 (en) Treatment of egfr-mutant cancer
BR112014012054A2 (pt) métodos de tratamento com deferiprona
SE0400184D0 (sv) New therapeutical use
CL2021003032A1 (es) Métodos de tratamiento de la urticaria crónica espontánea utilizando un inhibidor de la tirosina quinasa de bruton
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
DK1689404T3 (da) Kombination af et-743 med 5-fluoracil-prodrugs til behandling af cancer
EA200700433A1 (ru) Производные бетулинола в качестве агентов против вич (вируса иммунодефицита человека)
MX2023001570A (es) Composiciones y métodos para tratar o prevenir una enfermedad asociada a la infección por betacoronavirus.
DE602005009158D1 (de) Anti-hiv-chinuklidinverbindungen
RU2010146309A (ru) Фармацевтическая композиция для лечения фибромиалгии
DE602004030048D1 (de) Ffizienz
MX2022016406A (es) Metodos para tratar el cancer o enfermedad de von-hippel lindau usando una combinacion de un inhibidor de hif-2 alpha y lenvatinib.
MX2022016410A (es) Metodos para tratar el cancer o enfermedad de von-hippel lindau usando una combinacion de un antagonista del pd-1, inhibidor de hif-2 alpha y lenvatinib o una sal aceptable farmeuticamente de estos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee